ArticleJAMA2025

Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.

E Shelley Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.